MAY 18 • 11M Time matters: should British people with MS accept sup-optimal care? In the #AttackMS trial we are comparing starting natalizumab within 2 weeks of symptom onset to those starting natalizumab after 2 months. Yes, we really think time matters in MS. Listen now GAVIN GIOVANNONI Nothing is… Read more »
Posts Categorized: MS News
Pregnancy and Multiple Sclerosis Online Workshop on 24 May
MS-UK are running a workshop with Dr Ruth Dobson who will be presenting her work on the ‘UK consensus on pregnancy in multiple sclerosis’ published in the British Medical Journal (BMJ). The workshop takes place online on Tuesday 24 May 1.15pm to 2.15pm. The consensus was developed for clearer guidance for individuals and their treatment… Read more »
Make sure people with MS can access FES
The MS Society need your help to ensure that Functional Electrical Stimulation (FES) is consistently funded and prescribed for people with MS across the UK. FES is a treatment used to stimulate movement in weakened or paralysed muscles. It has been proven to improve the lives of many people with MS, making walking easier and reducing… Read more »
New drug approved for relapsing remitting MS in England and Wales
Vumerity (diroximel fumarate) approved for relapsing remitting MS in England and Wales The MS Trust have recently reported that Vumerity (diroximel fumarate) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis. NICE has recommended that Vumerity can be prescribed as a twice daily tablet for people with relapsing… Read more »
MS Society’s ‘Extra Costs of MS’ survey
The MS Society has launched a survey for people in the UK who have MS, or who live with someone who does, to find out about the extra costs of MS. The increasing cost of living is putting pressure on people across the UK and MS can cause living costs to mount up even further…. Read more »
Behind the headlines: Could an immunotherapy treatment for the Epstein-Barr virus (EBV) treat MS?
A new immunotherapy treatment in a trial for progressive MS hit the headlines recently. News reports say it could reverse or stabilise the progression of MS by targeting the Epstein-Barr virus (EBV). We looked behind the headlines to find out more. The trial was already underway when a study provided the strongest evidence yet that… Read more »
Research and MS, online webinar with the MS Society, Thursday 21 April
In MS Awareness Week, find out about the science behind MS and some of the latest developments in MS research. It will take place on Thursday 21 April 2022 at 7pm Join the MS Society Research team to find out about areas of work they are already funding, get up-to-date information on the latest ground-breaking research, and… Read more »
MS Trust webinars: MS Awareness Week
During MS Awareness Week the MS Trust will be hosting a series of webinars, covering everything from symptom management to work and finances. The webinars will feature tips and tricks from professionals who are trusted experts in their fields, along with people with MS who have generously agreed to share their own experiences.There will also be… Read more »
Spasticity online information session with MS-UK – Monday 25 April 2022
MS-UK are hosting a webinar called Spasticity – What it is and practical ways to manage the effects of spasticity. In this information session, Dr Gretchen Hawley will be discussing what spasticity is, how to recognise spasticity vs tightness and how you can manage its effects independently using the power of stretching. The session will last for approximately… Read more »
The MS Guide
